拉布多溶解是由提尔泽帕蒂德的启动引发的
Yoshiro Fushimi1, Tomohiko Kimura1, Junpei Sanada1
1Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Japan.
蒂尔泽帕提德是一种新的糖尿病药物,可能会导致严重的肌肉疾病 - - 拉布多米,一种严重的肌肉疾病. 监测肌酸激酶水平对于安全使用这种依赖葡萄糖的胰岛素聚 (GIP) 和类似葡萄糖-1 (GLP-1) 受体激动剂至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 蒂尔泽帕提德是一种新型的双GIP/GLP-1受体激动剂,用于治疗2型糖尿病 (T2DM).
- 患有T2DM的患者往往有并发症,如失脂症和慢性病 (CKD).
- 拉布多溶解是一种严重的疾病,涉及肌肉分解和释放肌球蛋白到血液中.
更多相关视频
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
Nephrotic Syndrome I : Introduction
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Renal Drug Excretion: Tubular Secretion
Renal Drug Excretion: Tubular Reabsorption
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
